Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2018-09-20
DOI
10.1080/21645515.2018.1515455
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV–Primed Children in the Philippines
- (2018) Maria Rosario Capeding et al. JOURNAL OF INFECTIOUS DISEASES
- Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand
- (2017) Tawee Chotpitayasunondh et al. VACCINE
- Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children
- (2016) Kulkanya Chokephaibulkit et al. VACCINE
- Modeling the Long-term Persistence of Hepatitis A Antibody After a Two-Dose Vaccination Schedule in Argentinean Children
- (2015) Eduardo L. López et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study
- (2015) Barbara Romanowski et al. Human Vaccines & Immunotherapeutics
- Epidemiology of Japanese encephalitis: past, present, and future prospects
- (2015) Guo-Dong Liang et al. Therapeutics and Clinical Risk Management
- Primary Immunization of Infants and Toddlers in Thailand with Japanese Encephalitis Chimeric Virus Vaccine in Comparison with SA14-14-2
- (2014) Emmanuel Feroldi et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults
- (2014) Niel Hens et al. VACCINE
- Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children
- (2013) Emmanuel Feroldi et al. Human Vaccines & Immunotherapeutics
- Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine
- (2012) Kamal Desai et al. VACCINE
- Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial
- (2012) Emmanuel Feroldi et al. Human Vaccines & Immunotherapeutics
- Estimated global incidence of Japanese encephalitis:
- (2011) Grant Campbell et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine
- (2011) Peter E. Nasveld et al. Human vaccines & immunotherapeutics
- Japanese Encephalitis: New Options for Active Immunization
- (2010) Scott B. Halstead et al. CLINICAL INFECTIOUS DISEASES
- Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-olds
- (2010) Kulkanya Chokephaibulkit et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials
- (2010) Joseph Torresi et al. VACCINE
- The BUGS project: Evolution, critique and future directions
- (2009) David Lunn et al. STATISTICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started